o-(2-fluoroethyl)tyrosine and Central-Nervous-System-Diseases

o-(2-fluoroethyl)tyrosine has been researched along with Central-Nervous-System-Diseases* in 1 studies

Other Studies

1 other study(ies) available for o-(2-fluoroethyl)tyrosine and Central-Nervous-System-Diseases

Article	Year
Neurosarcoidosis on FET and FDG PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:3 O-(2-fluoroethyl)-L-tyrosine (FET) PET/CT is a promising imaging modality for brain tumor imaging because of its reported high sensitivity for biologically active tumor tissue. We present a case of biopsy-proven neurosarcoidosis showing FET uptake. It is an important cause of false-positive uptake on FET PET/CT. Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine	2017

Article

Year

Clinical nuclear medicine, 2017, Volume: 42, Issue:3

O-(2-fluoroethyl)-L-tyrosine (FET) PET/CT is a promising imaging modality for brain tumor imaging because of its reported high sensitivity for biologically active tumor tissue. We present a case of biopsy-proven neurosarcoidosis showing FET uptake. It is an important cause of false-positive uptake on FET PET/CT.

Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine

2017